Recent studies suggest that ETV7 controls breast cancer inflammation by controlling the TNF-α axis and cross-talking with STAT3—an inflammation regulator—suggesting that VD3-GNPs therapeutically alter these pathway markers via ETV7 [14,15,16,17,18,19,20], which is a challenge for future studies. This evidence concerns the gene TNF and breast carcinoma.